Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1995 1
1996 1
1997 3
1999 4
2000 5
2001 7
2002 3
2003 5
2004 3
2005 4
2006 6
2007 7
2008 6
2009 6
2010 3
2011 6
2012 4
2013 5
2014 8
2015 10
2016 7
2017 4
2018 3
2019 2
2020 1
2021 3
2022 5
2023 2
2024 4
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for carcelain g
Search for Garcelain G instead (1 results)
PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study.
Delyon J, Biard L, Renaud M, Resche-Rigon M, Le Goff J, Dalle S, Heidelberger V, Da Meda L, Toullec L, Carcelain G, Mourah S, Caillat-Zucman S, Allain V, Battistella M, Lebbe C. Delyon J, et al. Among authors: carcelain g. Lancet Oncol. 2022 Apr;23(4):491-500. doi: 10.1016/S1470-2045(22)00097-3. Epub 2022 Mar 10. Lancet Oncol. 2022. PMID: 35279271 Clinical Trial.
Immune interventions in HIV infection.
Carcelain G, Autran B. Carcelain G, et al. Immunol Rev. 2013 Jul;254(1):355-71. doi: 10.1111/imr.12083. Immunol Rev. 2013. PMID: 23772631 Review.
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial.
Beaulieu M, Gaymard A, Massonnaud C, Peiffer-Smadja N, Bouscambert-Duchamp M, Carcelain G, Lingas G, Mentré F, Ader F, Hites M, Poignard P, Guedj J. Beaulieu M, et al. Among authors: carcelain g. J Antimicrob Chemother. 2024 Nov 4;79(11):2887-2895. doi: 10.1093/jac/dkae301. J Antimicrob Chemother. 2024. PMID: 39236218 Free PMC article. Clinical Trial.
Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group.
Spano JP, Poizot-Martin I, Costagliola D, Boué F, Rosmorduc O, Lavolé A, Choquet S, Heudel PE, Leblond V, Gabarre J, Valantin MA, Solas C, Guihot A, Carcelain G, Autran B, Katlama C, Quéro L. Spano JP, et al. Among authors: carcelain g. Ann Oncol. 2016 Mar;27(3):397-408. doi: 10.1093/annonc/mdv606. Epub 2015 Dec 17. Ann Oncol. 2016. PMID: 26681686 Free article. Review.
Therapeutic vaccines for chronic infections.
Autran B, Carcelain G, Combadiere B, Debre P. Autran B, et al. Among authors: carcelain g. Science. 2004 Jul 9;305(5681):205-8. doi: 10.1126/science.1100600. Science. 2004. PMID: 15247470
Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease.
Martin de Frémont G, Vanjak A, Sbihi Z, Knapp S, Garzaro M, Chbihi M, Fournier B, Poirot J, Dossier A, Silvestrini MA, Villemonteix J, Meignin V, Galicier L, Bertinchamp R, Le Goff J, Salmona M, Flamarion E, Cassius C, Lebbé C, Ronchetti AM, Latour S, Oksenhendler E, Carcelain G, Boutboul D. Martin de Frémont G, et al. Among authors: carcelain g. Blood Adv. 2023 May 9;7(9):1682-1691. doi: 10.1182/bloodadvances.2022008456. Blood Adv. 2023. PMID: 36508281 Free PMC article.
121 results